| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.14 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |